Eli Lilly and Co News

World's Biggest Hedge Fund Sells Apple, Eli Lilly Stock, and Buys Microsoft, Moderna -- Barrons.com

Barron's03:00 ET

Eli Lilly and Co (LLY.US) filed for a new indication for its blockbuster drug "teplipotide" in China for market approval.

The latest announcement on the website of the China National Medical Products Administration's Pharmaceutical Evaluation Center (CDE) reveals that Eli Lilly and Co (LLY.US)'s blockbuster drug GIP/GLP-1 receptor dual agonist tirzepatide injection has obtained acceptance for a new indication, but the specific indication has not been disclosed.

Zhitong Finance21:59 ET

Executive Reshuffles: LLY, S and RY Companies in Focus

Seeking Alpha16:21 ET

Is Eli Lilly and Company (LLY) an Unstoppable Dividend Stocks to Buy?

Yahoo Finance13:55 ET

BMO Capital Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Maintains Target Price $1,101

Moomoo NewsSep 13 19:31 ET · Ratings

Correction to Eli Lilly Gets FDA Approval for Eczema Treatment Article

Dow JonesSep 13 17:49 ET

Express News | Eli Lilly: Ebglyss Will Be Available in United States in Coming Weeks

ReutersSep 13 16:09 ET

Express News | FDA Approves Lilly's Ebglyss™ (Lebrikizumab-Lbkz) for Adults and Children 12 Years and Older With Moderate-to-Severe Atopic Dermatitis

ReutersSep 13 16:07 ET

Eli Lilly Investing $1.8B to Expand Its Manufacturing Facilities

Yahoo FinanceSep 13 11:13 ET

Eli Lilly Analyst Ratings

BenzingaSep 13 09:43 ET · Ratings

Bullish on the future of the "weight-loss miracle drug" Tesofensine, Citigroup reinitiates coverage of eli lilly and co (LLY.US) with a "buy" rating.

Citigroup rates Eli Lilly and Co (LLY.US) as 'buy' with a target price of $1060.

Zhitong FinanceSep 13 09:35 ET

BofA Securities Initiates Eli Lilly and Co(LLY.US) With Buy Rating

Moomoo NewsSep 13 09:32 ET · Ratings

J.P. Morgan Maintains Eli Lilly and Co(LLY.US) With Buy Rating, Raises Target Price to $1,100

Moomoo NewsSep 13 07:33 ET · Ratings

Citi Initiates Eli Lilly and Co(LLY.US) With Buy Rating, Announces Target Price $1,060

Moomoo NewsSep 13 05:31 ET · Ratings

Eli Lilly & Co (LLY) Gets a Buy From Citi

TipRanksSep 13 04:56 ET · Ratings

Express News | Eli Lilly : JP Morgan Raises Target Price to $1,100 From $1,050

ReutersSep 13 00:20 ET

FDA Approves Lilly's EBGLYSS (Lebrikizumab-lbkz) for Adults and Children 12 Years and Older With Moderate-to-Severe Atopic Dermatitis

Eli Lilly & Co.Sep 13 00:00 ET

Eli Lilly to Expand Two Ireland Sites With $1.8 Billion Investment

MT NewswiresSep 12 23:41 ET

Technology stocks led the S&P to four consecutive gains, Oracle reached a new high after hours, the US dollar and US bonds fell, gold hit a new high, and commodities rose.

In August, the PPI in the United States showed a cooling down of inflation, and the market slightly raised its bets on the Fed's aggressive interest rate cuts. US stocks rose together, with Nvidia up nearly 2%, while NIO Inc and XPeng fell more than 5%. The European Central Bank cut interest rates for the second time this year, but maintained a restrictive policy. European bonds fell, and the euro rebounded from its four-week low. Commodities rose across the board, with US oil briefly rising by 3.7%, gold reaching a new high with a nearly 2% increase, palladium rising by over 4%, and copper experiencing its largest two-month increase.

wallstreetcnSep 12 19:04 ET

US stocks closed: Technology breaks through to lift the index, Nasdaq and S&P jointly achieve four consecutive gains.

① After four consecutive days of gains, the S&P 500 index is still 1.3% away from its historical high. ② Warren Buffett's deputy sold more than half of Berkshire Hathaway's positions, causing the stock price to fall for the seventh consecutive day. ③ AirPods Pro transforms into an OTC hearing aid, with FDA approval for Apple's hearing assistance software. ④ Gilead's HIV prevention drug delivers positive results once again.

cls.cnSep 12 18:22 ET